Ruling in Sisvel v Haier clarifies issues around areas including what constitutes a “willing” licensee, obligations on implementers and the scope licensors have to vary royalty rates
Fortress’s offer for Finjan means another PIPCO is set to disappear and confirms that in the IP monetisation business it is now the giants that rule the roost Read more
The 2020 edition of the IAM Patent 1000 features in-depth analysis of the markets in 48 key jurisdictions and is based on thousands of submissions, interviews and client references Read more
Remarks made by Xi Jinping suggest that if a Chinese company develops a covid-19 cure, compulsory licensing’s big moment might not arrive after all Read more
Big-name electronics and chemical companies have continued to sign on, but several have taken the opportunity to narrow the terms of the pledge and remind potential infringers that they won’t tolerate abuse Read more
Opponents of stronger laws have seized the opportunity created by the pandemic to build a narrative that will make legislative changes to the 101 regime almost impossible to secure Read more
Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more
A look into the IAM back catalogue to see how we have covered the developing face of IP strategy in one of the world's great innovation powers Read more
A UK Supreme Court justice, a former USPTO acting director, a globally-renowned IP scholar, a trailblazing trademark lawyer and a one-time presidential candidate form the class of 2020 Read more
First post-grant decision in the technology sector nevertheless gives some hope to gut bacteria innovators, despite invalidating a key cancer treatment patent Read more
Leading in-house and private practice lawyers share their experiences of working in the shadow of a pandemic and explain what they believe might happen next Read more
Despite the improving Chinese IP environment and trade deal commitments, long-term personal relationships are likely to be increasingly important in getting transactions over the line Read more
Ian McClure explains why the current covid-19 crisis could herald a revolution in the academic institutions’ licensing efforts, but also warns of potential dangers ahead Read more
The agency's former Commissioner of Patents says it’s so far so good at the office - but explains why a backlog may build at the end of the year Read more
We use cookies on www.iam-media.com. By using this site, you agree that we may store and access cookies on your device. For further information please read our cookie policy and our terms and conditions.
